| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 118 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 118 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 118 |
| 3 | DROSPIRENONE AND ETHINYL ESTRADIOL | 117 |
| 4 | METHOTREXATE SODIUM | 108 |
| 5 | METHOTREXATE | 85 |
| 6 | PREDNISONE | 75 |
| 7 | FLUOROURACIL | 68 |
| 8 | FLUOROURACIL CREAM, 0.5% | 68 |
| 9 | PACLITAXEL | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARBAMIDE PEROXIDE 6.5% | 1 | 0.0222 |
| 1 | ADENINE | 1 | 0.0204 |
| 2 | SENNOSIDES, STIMULANT LAXATIVE | 1 | 0.0139 |
| 3 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 4 | IDARUBICIN HYDROCHLORIDE | 7 | 0.0060 |
| 5 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 8 | 0.0044 |
| 6 | DICLOXACILLIN SODIUM | 4 | 0.0044 |
| 7 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 8 | ZIV-AFLIBERCEPT | 5 | 0.0038 |
| 9 | ARGATROBAN | 5 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 205 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 143 |
| 2 | Alkylating Drug [EPC] | 132 |
| 3 | Platinum-based Drug [EPC] | 117 |
| 4 | Factor Xa Inhibitor [EPC] | 97 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 94 |
| 6 | Microtubule Inhibitor [EPC] | 91 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 86 |
| 8 | Proton Pump Inhibitor [EPC] | 64 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 62 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human C1 Esterase Inhibitor [EPC] | 6 | 0.0015 |
| 1 | PCSK9 Inhibitor [EPC] | 35 | 0.0014 |
| 2 | Anti-coagulant [EPC] | 5 | 0.0013 |
| 3 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 10 | 0.0011 |
| 5 | Actinomycin [EPC] | 2 | 0.0009 |
| 6 | Asparagine-specific Enzyme [EPC] | 12 | 0.0009 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 8 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 9 | Progesterone [EPC] | 17 | 0.0007 |